| Literature DB >> 32934622 |
Suma Mary Thampi1, Riya Jose1, Poornima Kothandan2, Meghna Jiwanmall1, Ekta Rai1.
Abstract
BACKGROUND AND AIMS: Anaesthesia for children undergoing magnetic resonance imaging (MRI) ranges from moderate to deep sedation in order to facilitate uninterrupted completion of the scan. While various intravenous and inhalational techniques of anaesthesia have their own merits and demerits, there is a paucity of comparative literature between the two in children undergoing diagnostic MRI.Entities:
Keywords: Anaesthesia recovery period; cohort analysis; general anaesthesia; inhalational anaesthesia; magnetic resonance imaging; propofol
Year: 2020 PMID: 32934622 PMCID: PMC7458030 DOI: 10.4103/sja.SJA_741_19
Source DB: PubMed Journal: Saudi J Anaesth
Definitions of variables used to measure primary and secondary outcomes
| Variables measured | Definitions |
|---|---|
| Time to induction | Time from induction of anaesthesia till deemed ready to be shifted into MRI gantry, as judged by a UMSS score of 2 or more |
| Time to emergence | From discontinuation of anaesthetic modality till wakefulness (eye opening, purposeful movement to command) |
| Respiratory adverse events | Inclusive of but not limited to apnea, laryngospasm, bronchospasm, airway obstruction requiring intervention in the form of chin lift, head tilt, insertion of oral airway or LMA |
| Non-respiratory adverse events | Inclusive of but not limited to bradycardia, emergence delirium (assessed by PAED scale), oversedation and frequency of nausea and vomiting |
This table defines the primary outcomes (time to induction and time to recovery) and secondary outcomes (adverse event profiles) as defined in the study (UMSS=University of Michigan Sedation Scale; PAED=Paediatric Anaesthesia Emergence Delirium score)
Definition of adverse events
| Adverse event | Definition |
|---|---|
| Apnea | Cessation of visible breathing movements for 10 sec or more, with or without oxygen desaturation |
| Airway obstruction | Noisy breathing requiring chin lift, head tilt, insertion of oral airway or LMA |
| Oxygen desaturation | Saturation of <94% of any duration, whether or not intervention was required |
| Laryngospasm | Complete or partial, requiring intervention with 100% oxygen, continuous positive airway pressure, jaw thrust, propofol bolus or succinylcholine |
| Bradycardia | Decrease in heart rate of >25% from baseline or <60 per minute |
This table defined respiratory and non-respiratory adverse events which were included in the secondary outcomes studied
Demographic data
| Variables | Total (%) | GSP (%) | GAL (%) | |
|---|---|---|---|---|
| Age (years)a | 4.0 (2.0, 6.5) | 4.0 (2.0, 7.0) | 3.0 (1.5, 6.0) | 0.241 |
| Male | 67 (62.6) | 39 (68.4) | 28 (56.0) | 0.185 |
| Weight (kilograms)a | 13.5 (10.0, 18.0) | 14.0 (11.0, 19.0) | 12.0 (9.0, 16.9) | 0.029 |
| Indications for Scan: | ||||
| Developmental delay | 47 (43.9) | 28 (49.1) | 19 (38.0) | 0.247 |
| Behavioural disorders | 28 (26.2) | 16 (28.1) | 12 (24.0) | 0.722 |
| Tumours | 21 (19.6) | 12 (21.1) | 9 (18.0) | |
| Epilepsy | 20 (18.7) | 12 (21.1) | 8 (16.0) | |
| Hearing loss | 7 (6.5) | 2 (3.5) | 5 (10.0) | |
| Follow-up | 17 (15.9) | 9 (15.8) | 8 (16.0) | |
| Others | 14 (13.1) | 6 (10.5) | 8 (16.0) | |
| On antiepileptic medication | 44 (41.1) | 26 (45.6) | 18 (36.0) | 0.313 |
| Bronchial asthma | 3 (2.8) | 2 (3.5) | 1 (2.0) | 1.000 |
| Current respiratory infection | 15 (14.0) | 11 (19.3) | 4 (8.0) | 0.093 |
| Recent respiratory infection | 11 (10.3) | 9 (15.8) | 2 (4.0) | 0.045 |
| MRI site | ||||
| Brain | 78 (72.9) | 42 (73.7) | 36 (72.0) | - |
| Brain and spine | 5 (4.7) | 2 (3.5) | 3 (6.0) | |
| Extremity | 4 (3.7) | 3 (5.3) | 1 (2.0) | |
| Pelvis | 3 (2.8) | 2 (3.5) | 1 (2.0) | |
| Spine | 6 (5.6) | 4 (7.0) | 2 (4.0) | |
| Abdomen | 2 (1.9) | 2 (3.5) | 0 (0.0) | |
| Head and neck | 7 (6.5) | 2 (3.5) | 5 (10.0) | |
| Thorax | 2 (1.9) | 0 (0.0) | 2 (4.0) | |
| MRI scan duration (min)b | 43.9±15.5 | 44.1±16.9 | 43.7±13.9 | 0.885 |
aMedian and Inter Quartile Range (IQR); bMean and Standard Deviation (SD)
Figure 1(a) Box plot depicting the median time to induction in the general anaesthesia (GAL) and propofol sedation (GSP) groups [10.0 minutes (IQR 8.8, 13.0) versus 7 minutes (IQR 5.0, 10.0), P < 0.001) respectively. (b) Box plot showing the median time to recovery in the GAL and GSP groups (20.0 minutes (IQR 10.0, 31.3), P value 0.13) versus 25.0 minutes (IQR 15.0, 40.0)
Frequency of adverse events in the GSP and GAL groups
| Variables | Total (%) | GSP (%) | GAL (%) | |
|---|---|---|---|---|
| Desaturation | 9 (8.4) | 1 (1.8) | 8 (16.0) | 0.012 |
| Airway obstruction | 8 (7.5) | 2 (3.5) | 6 (12.0) | 0.143 |
| Laryngospasm | 12 (11.3 | 1 (1.8) | 11 (22.4) | 0.001 |
| Bradycardia | 6 (5.6) | 5 (8.8) | 1 (2.0) | 0.212 |
| Nausea | 1 (0.9) | - | 1 (2.0) | 0.947 |
| Vomiting | 3 (2.8) | 1 (1.8) | 2 (4.0) | 0.598 |
| Emergence delirium | 5 (4.7) | - | 5 (10.0) | 0.047 |
Adverse Events in the GSP and GAL groups: There is a greater frequency of respiratory adverse events such as desaturation and laryngospasm, as well as non-respiratory adverse events such as emergence delirium, in the GAL group